C&EN Monthly - March 2024

Want more breaking chemistry news? Get the latest news distilled to your inbox?every week. Subscribe now to our weekly email newsletter

Here are some of the top articles from cen.acs.org that have been creating a reaction:

2024 Priestley Medalist Carolyn Bertozzi has built a unique culture. Carolyn Bertozzi is a scientific celebrity. But it wasn’t always that way: as a young chemist, Bertozzi struggled to make her way into the field. C&EN follows how the culture of chemistry has changed throughout Bertozzi’s career—and how she, in turn, has changed the culture.

Competition to destroy ‘forever chemicals’ heats up. In the face of looming regulations and growing liability risks, companies are seeking help in managing waste containing per- and polyfluoroalkyl substances (PFAS), also known as “forever chemicals.”

Mighty MXenes are ready for launch. MXenes may soon play a transformative role in energy storage, electronics, optics, biomedicine, and catalysis. Many companies have MXene licenses and patents, and companies are on the verge of launching the first commercial products.

Structures of new drug candidates revealed. On Wednesday, the popular “First-time disclosures” session of the ACS Spring 2024 meeting, in the Division of Medicinal Chemistry, offered a look behind the curtain of the drug development pipeline with the unveiling of the structures of new clinical candidates.

New schizophrenia medications could signal a comeback for psychiatric drugs. If the FDA gives KarXT the green light, the drug will be the first truly new treatment for schizophrenia in decades.

Don't miss out on the latest breaking developments in chemistry. Subscribe now to our weekly email newsletter and get a first look at the latest and most comprehensive overview of the chemical world, distilled to your inbox every week.